Patent Application Titled 'Cgrp Antagonists For The Treatment Of Medication Overuse Headache, Post-Traumatic Headache, Post-Concussion Syndrome And Vertigo' Published Online (USPTO 20200383983)

MLA

“Patent Application Titled ‘Cgrp Antagonists For The Treatment Of Medication Overuse Headache, Post-Traumatic Headache, Post-Concussion Syndrome And Vertigo’ Published Online (USPTO 20200383983).” Obesity, Fitness & Wellness Week, Jan. 2021, p. 472. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.646731711&authtype=sso&custid=ns315887.

APA

Patent Application Titled “Cgrp Antagonists For The Treatment Of Medication Overuse Headache, Post-Traumatic Headache, Post-Concussion Syndrome And Vertigo” Published Online (USPTO 20200383983). (2021, January 2). Obesity, Fitness & Wellness Week, 472.

Chicago

Obesity, Fitness & Wellness Week. 2021. “Patent Application Titled ‘Cgrp Antagonists For The Treatment Of Medication Overuse Headache, Post-Traumatic Headache, Post-Concussion Syndrome And Vertigo’ Published Online (USPTO 20200383983),” January 2. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.646731711&authtype=sso&custid=ns315887.